CLINICAL_TRIALS
trial_result
· 2019-03-20
Clinical Trial Update: Absorption & Elimination of Radiolabelled GSK2269557 [Phase 1]
Summary
Phase 1 trial update on absorption and elimination of radiolabeled GSK2269557; results completed and posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED | Results posted: 2019-03-20